Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00884039 · ClinicalTrials.gov registry record · NA
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
A NA study, sponsored by Cornea Research Foundation of America.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00884039 is a NA study that was terminated before completion, run by Cornea Research Foundation of America. The registered enrollment target is 7 participants.
The verdict
NCT00884039, a NA study, was terminated before completion, sponsored by Cornea Research Foundation of America.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will investigate the use of anecortave acetate injection to reduce intraocular pressure (IOP) in corneal transplant recipients who are experiencing steroid-associated pressure control problems. Alternative methods of IOP control have been shown to entail serious risks. For example, reduction of topical steroids increases the risk of graft rejection, and use of glaucoma medications or glaucoma surgery increases the risk of graft failure. This study is designed to have sufficient power to detect whether a single injection can induce a clinically significant IOP reduction.
Interventions
- DRUG anecortave acetate
- DRUG 30 mg anecortave acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00884039
The ClinicalTrials.gov registry entry for NCT00884039 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornea Research Foundation of America, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which anecortave acetate is the first listed.
NCT00884039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00884039 about?
NCT00884039 is a clinical study titled "Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients". This study will investigate the use of anecortave acetate injection to reduce intraocular pressure (IOP) in corneal transplant recipients who are experiencing steroid-associated pressure control problems. Alternative methods of IOP control have been shown to entail serious risks. For example, reduct...
What is the current status of trial NCT00884039?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2009-05. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00884039?
The interventions under investigation include: anecortave acetate (DRUG), 30 mg anecortave acetate (DRUG).
Who is sponsoring clinical trial NCT00884039?
This trial is sponsored by Cornea Research Foundation of America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.